DK1007686T3 - Tuberkulosevaccine - Google Patents
TuberkulosevaccineInfo
- Publication number
- DK1007686T3 DK1007686T3 DK98947427T DK98947427T DK1007686T3 DK 1007686 T3 DK1007686 T3 DK 1007686T3 DK 98947427 T DK98947427 T DK 98947427T DK 98947427 T DK98947427 T DK 98947427T DK 1007686 T3 DK1007686 T3 DK 1007686T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- acid molecules
- present
- tuberculosis vaccine
- novel recombinant
- Prior art date
Links
- 229960002109 tuberculosis vaccine Drugs 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97114614A EP0902086A1 (en) | 1997-08-22 | 1997-08-22 | Tuberculosis vaccine |
| PCT/EP1998/005109 WO1999010496A1 (en) | 1997-08-22 | 1998-08-12 | Tuberculosis vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1007686T3 true DK1007686T3 (da) | 2007-04-10 |
Family
ID=8227261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98947427T DK1007686T3 (da) | 1997-08-22 | 1998-08-12 | Tuberkulosevaccine |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6673353B1 (ja) |
| EP (2) | EP0902086A1 (ja) |
| JP (1) | JP4255209B2 (ja) |
| AT (1) | ATE347599T1 (ja) |
| AU (1) | AU9435098A (ja) |
| CA (1) | CA2301879C (ja) |
| CY (1) | CY1106350T1 (ja) |
| DE (1) | DE69836588T2 (ja) |
| DK (1) | DK1007686T3 (ja) |
| ES (1) | ES2274580T3 (ja) |
| PT (1) | PT1007686E (ja) |
| SI (1) | SI1007686T1 (ja) |
| WO (1) | WO1999010496A1 (ja) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7794729B2 (en) | 1994-11-08 | 2010-09-14 | The Trustees Of The University Of Pennsylvania | Methods and compositions for immunotherapy of cancer |
| US8114414B2 (en) | 1994-11-08 | 2012-02-14 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical cancer |
| US7662396B2 (en) | 2001-03-26 | 2010-02-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| US7820180B2 (en) * | 2004-09-24 | 2010-10-26 | The Trustees Of The University Of Pennsylvania | Listeria-based and LLO-based vaccines |
| US8956621B2 (en) | 1994-11-08 | 2015-02-17 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical dysplasia |
| US8791237B2 (en) | 1994-11-08 | 2014-07-29 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of non-hodgkins lymphoma |
| US6051237A (en) * | 1994-11-08 | 2000-04-18 | The Trustees Of The University Of Pennsylvania | Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| ID29858A (id) | 1998-11-04 | 2001-10-18 | Isis Innovation | Uji diagnostik tuberkulosis |
| GB0006693D0 (en) * | 2000-03-20 | 2000-05-10 | Glaxo Group Ltd | Vaccine |
| US9012141B2 (en) | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
| US6855320B2 (en) | 2000-03-29 | 2005-02-15 | The Trustees Of The University Of Pennsylvania | Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity |
| JP2004500405A (ja) * | 2000-03-29 | 2004-01-08 | ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア | 抗原の免疫原性を増強するための組成物および方法 |
| US7700344B2 (en) | 2001-03-26 | 2010-04-20 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| US8771702B2 (en) | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| PT1592441E (pt) * | 2003-02-06 | 2012-05-21 | Aduro Biotech | Listeria atenuada relativamente à entrada em células não patogénicas, vacinas compreendendo a listeria e métodos para sua utilização |
| CA2523084C (en) | 2003-04-23 | 2012-09-04 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Tuberculosis vaccine with improved efficacy |
| EP1649869A1 (en) * | 2004-10-21 | 2006-04-26 | Vakzine Projekt Management GmbH | Combination of a recombinant mycobacterium and a biologically active agent as a vaccine |
| CA2589204C (en) | 2004-12-01 | 2013-10-29 | Aeras Global Tb Vaccine Foundation | Recombinant bcg strains with enhanced ability to escape the endosome |
| US8268326B2 (en) | 2006-08-15 | 2012-09-18 | The Trustees Of The University Of Pennsylvania | Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof |
| DK2977456T3 (en) | 2006-08-15 | 2018-01-22 | Univ Pennsylvania | Compositions comprising HMW-MAA and fragments thereof for the treatment of cancer |
| EP2288379A4 (en) | 2008-05-19 | 2012-08-08 | Advaxis | DOUBLE RELEASE SYSTEM FOR HETEROLOGIST ANTIGENE |
| US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
| US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
| ES2637068T3 (es) | 2009-03-04 | 2017-10-10 | The Trustees Of The University Of Pennsylvania | Composiciones que comprenden factores angiogénicos y métodos de uso de las mismas |
| US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
| PT2618837T (pt) | 2010-09-20 | 2018-10-18 | Vakzine Projekt Man Gmbh | Micobactérias recombinantes como vacina para uso em humanos |
| JP5981436B2 (ja) | 2010-10-01 | 2016-08-31 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 寄生的に感染している対象におけるワクチン不応答性を反転させるためのリステリアワクチンベクターの使用 |
| KR101832019B1 (ko) | 2010-12-21 | 2018-02-23 | 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. | 백신으로서의 재조합 마이코박테리움 |
| CA2822715C (en) | 2010-12-21 | 2019-04-30 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Determination of the efficacy of an anti-mycobacterial vaccination |
| EP3332804A1 (en) | 2011-03-11 | 2018-06-13 | Advaxis, Inc. | Listeria-based adjuvants |
| BR102012003790A2 (pt) | 2012-02-17 | 2014-04-22 | Fundacao Butantan | Cepa de mycobacterium recombinante, composição imunogênica e uso |
| BR112014022662A2 (pt) | 2012-03-12 | 2017-10-03 | Advaxis Inc | Inibição da função de célula supressora seguindo tratamento de vacina de listeria |
| EP2834356A4 (en) * | 2012-04-02 | 2015-09-02 | Univ Arizona | RECOMBINANT BACTERIUM FOR INDUCING A CELLULAR IMMUNE RESPONSE |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5504005A (en) * | 1987-03-02 | 1996-04-02 | Albert Einstein College Of Medicine Of Yeshiva University | Recombinant mycobacterial vaccine |
-
1997
- 1997-08-22 EP EP97114614A patent/EP0902086A1/en not_active Withdrawn
-
1998
- 1998-08-12 CA CA2301879A patent/CA2301879C/en not_active Expired - Lifetime
- 1998-08-12 DE DE69836588T patent/DE69836588T2/de not_active Expired - Lifetime
- 1998-08-12 SI SI9830871T patent/SI1007686T1/sl unknown
- 1998-08-12 EP EP98947427A patent/EP1007686B1/en not_active Expired - Lifetime
- 1998-08-12 ES ES98947427T patent/ES2274580T3/es not_active Expired - Lifetime
- 1998-08-12 AU AU94350/98A patent/AU9435098A/en not_active Abandoned
- 1998-08-12 US US09/485,717 patent/US6673353B1/en not_active Expired - Lifetime
- 1998-08-12 DK DK98947427T patent/DK1007686T3/da active
- 1998-08-12 JP JP2000507804A patent/JP4255209B2/ja not_active Expired - Lifetime
- 1998-08-12 PT PT98947427T patent/PT1007686E/pt unknown
- 1998-08-12 WO PCT/EP1998/005109 patent/WO1999010496A1/en active IP Right Grant
- 1998-08-12 AT AT98947427T patent/ATE347599T1/de active
-
2007
- 2007-03-01 CY CY20071100297T patent/CY1106350T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999010496A1 (en) | 1999-03-04 |
| PT1007686E (pt) | 2007-03-30 |
| EP0902086A1 (en) | 1999-03-17 |
| CA2301879C (en) | 2014-02-04 |
| DE69836588D1 (de) | 2007-01-18 |
| JP4255209B2 (ja) | 2009-04-15 |
| DE69836588T2 (de) | 2007-04-05 |
| CY1106350T1 (el) | 2011-10-12 |
| JP2001514000A (ja) | 2001-09-11 |
| EP1007686B1 (en) | 2006-12-06 |
| AU9435098A (en) | 1999-03-16 |
| US6673353B1 (en) | 2004-01-06 |
| CA2301879A1 (en) | 1999-03-04 |
| SI1007686T1 (sl) | 2007-04-30 |
| ES2274580T3 (es) | 2007-05-16 |
| ATE347599T1 (de) | 2006-12-15 |
| EP1007686A1 (en) | 2000-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69836588D1 (de) | Tuberkulose impfstoff | |
| HK1091217A1 (en) | Tuberculosis vaccine with improved efficacy | |
| BRPI9912663B8 (pt) | vacina contra cáncer e polipeptìdeo. | |
| DE69131580T2 (de) | GDF-1 und UOG1 Proteine | |
| DE69734882D1 (de) | Dna immunisierung gegen chlamydia infektion | |
| DK1025211T3 (da) | Hyaluronansyntasegen og anvendelser deraf | |
| ATE429504T1 (de) | Proteinexpressionsvektor und benutzung desselbigen | |
| DE69930955D1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
| DE69840332D1 (de) | Rekombinantes respiratorische synzytialvirus expressionssystem und impfstoffe | |
| DK251890D0 (da) | Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering | |
| ATE295423T1 (de) | Phosphodiesterase 8 | |
| DE69230671T2 (de) | Impfstoffe gegen actinobacillus pleuropneumonie | |
| ATE183241T1 (de) | Impstoff gegen streptococcus suis-infektion | |
| GB9922361D0 (en) | Generating an immune response to an antigen | |
| NO983946D0 (no) | Parapoksyviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner | |
| FI20070041A (fi) | Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin | |
| DE69836520D1 (de) | Clostridium perfringens Impfstoff | |
| BR0011469A (pt) | Gm-csf equina | |
| CY2008005I2 (el) | Εμβολιο κατα της παρωτιτιδας που περιεχει στελεχος ιου jeryl-lynn | |
| CA2148369A1 (en) | Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof | |
| DE60124380D1 (de) | Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure | |
| DE69530295D1 (de) | Leishmania hauptprotein, dafür kodierende nukleinsaüre und verwendungen davon | |
| BR0016740A (pt) | Antìgenos de esporozoìto de cryptosporidium | |
| NO871737D0 (no) | Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid. |